Three researchers who are recipients of a collaborative grant from the Samuel Waxman Cancer Research Foundation have developed a new type of drug designed to kill non-Hodgkin lymphoma tumor cells.
Researchers develop new type of drug to kill non-Hodgkin lymphoma tumor cells